Search
for
Sort by
Research 61–90 of 528
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- Ritlecitinib: First Approval
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Current Trends and Emerging Paradigms in the Treatment of Alopecia Areata
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Janus kinase inhibitors for alopecia areata: A narrative review
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Janus kinase inhibitors for alopecia areata
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- SYSTEMATIC REVIEW OF ORAL JANUS KINASE INHIBITORS IN ALOPECIA AREATA: INSIGHTS FROM 2020 TO 2025 STUDIES